Measuring insulin in human vitreous humour using LC-MS/MS

Drug Testing and Analysis

Volumn 4, Issue 1, 2012, Pages 53-56

  Thevis, Mario ^a   Thomas, Andreas ^a   Schänzer, Wilhelm ^a   Östman, Pekka ^b   Ojanperä, Ilkka ^b  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Homicide; Insulin; Mass spectrometry; Murder; Orbitrap

Indexed keywords

DIAGNOSIS; ENDOCRINOLOGY; INSULIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

CLINICAL DIAGNOSIS; HOMICIDE; LC-MS-MS; MATRIX; MURDER; ORBITRAP; POST MORTEM; POSTMORTEM ANALYSIS; THERAPEUTIC AGENTS; VITREOUS HUMOR;

PEPTIDES;

INSULIN;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; DRUG DETERMINATION; DRUG OVERDOSE; FEMALE; FORENSIC IDENTIFICATION; HUMAN; HYPERINSULINEMIA; IMMUNOPURIFICATION; PRIORITY JOURNAL; PURIFICATION; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VITREOUS BODY;

EID: 84856387489     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.368     Document Type: Article

References (24)

1. L. Rosenfeld Insulin: Discovery and controversy. Clin. Chem. 2002, 48, 2270.
2. V. Marks Murder by insulin. Med. Leg. J. 1999, 67, 147.
3. V. Marks Murder by insulin: Suspected, purported and proven - a review. Drug Test. Analysis 2009, 1, 162.
4. R. P. Green, A. S. Hollander, M. Thevis, A. Thomas, D. J. Dietzen Detection of surreptitious administration of analog insulin to an 8-week-old infant. Pediatrics 2010, 125, e1236.
5. G. Kernbach-Wighton, K. Püschel On the phenomenology of lethal applications of insulin. Forensic Sci. Int. 1998, 93, 61.
6. D. C. Winston Suicide via insulin overdose in nondiabetics: The New Mexico experience. Am. J. Forensic Med. Pathol. 2000, 21, 237.
7. S. M. Darby, M. L. Miller, R. O. Allen, M. LeBeau A mass spectrometric method for quantitation of intact insulin in blood samples. J. Anal. Toxicol. 2001, 25, 8.
8. A. D. Kippen, F. Cerini, L. Vadas, R. Stöcklin, L. Vu, R. E. Offord, K. Rose Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassays. J. Biol. Chem. 1997, 272, 12513.
9. M. Thevis, A. Thomas, P. Delahaut, A. Bosseloir, W. Schänzer Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2006, 78, 1897.
10. M. Thevis, A. Thomas, P. Delahaut, A. Bosseloir, W. Schänzer Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal. Chem. 2005, 77, 3579.
11. M. Thevis, A. Thomas, W. Schänzer Mass spectrometric determination of insulins and their degradation products in sports drug testing. Mass Spectrom. Rev. 2008, 27, 35.
12. M. Thevis, A. Thomas, W. Schänzer Insulin. Handb. Exp. Pharmacol. 2010, 195, 209.
13. A. Thomas, W. Schänzer, P. Delahaut, M. Thevis Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high resolution/high accuracy mass spectrometry. Drug Test. Analysis 2009, 1, 219.
14. A. Thomas, M. Thevis, P. Delahaut, A. Bosseloir, W. Schänzer Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Anal. Chem. 2007, 79, 2518.
15. F. Musshoff, C. Hess, B. Madea Disorders of glucose metabolism: post mortem analyses in forensic cases--part II. Int. J. Legal Med. 2011, 125, 171.
16. J. W. Cantrell, J. M. Hochholzer, C. S. Frings Effect of hemolysis on the apparent concentration of insulin in plasma. Clin. Chem. 1972, 18, 1423.
17. W. Q. Sturner, J. C. Garriott Comparative toxicology in vitreous humor and blood. Forensic Sci. 1975, 6, 31.
18. A. Pelander, J. Ristimaa, I. Ojanpera Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry. J. Anal. Toxicol. 2010, 34, 312.
19. J. Barar, A. R. Javadzadeh, Y. Omidi Ocular novel drug delivery: Impacts of membranes and barriers. Expert Opin. Drug Deliv. 2008, 5, 567.
20. H. Atluri, B. S. Anand, J. Patel, A. K. Mitra Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration. Exp. Eye Res. 2004, 78, 815.
21. K. Yamane, A. Minamoto, H. Yamashita, H. Takamura, Y. Miyamoto-Myoken, K. Yoshizato, T. Nabetani, A. Tsugita, H. K. Mishima Proteome analysis of human vitreous proteins. Mol. Cell. Proteomics. 2003, 2, 1177.
22. T. K. Shires, K. J. Braddock, J. S. Pulido Insulin in the vitreous of the normal and streptozotocin-induced diabetic rat. Peptides 1992, 13, 671.
23. E. M. Rocha, D. A. Cunha, E. M. Carneiro, A. C. Boschero, M. J. Saad, L. A. Velloso Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest. Ophthalmol. Vis. Sci. 2002, 43, 963.
24. K. D. Tinworth, P. C. Wynn, R. C. Boston, P. A. Harris, M. N. Sillence, M. Thevis, A. Thomas, G. K. Noble Evaluation of commercially available assays for the measurement of equine insulin. Domest. Anim. Endocrin. 2011, 41, 81.